Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 24, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations for the...
-
Nov 16, 2021New facility will expand BD’s capacity to supply the European market with pre-fillable syringes for use in applications such as vaccines and other biologic drugs; add 150 local jobs by 2024.
FRANKLIN LAKES, N.J. (November 16, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, broke ground on a €165 million ($200 million USD)...
-
Nov 12, 2021- Innovation agenda focuses on advancing human health through smart connected care, new care settings and chronic disease outcomes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
-
Nov 4, 2021- Fourth fiscal quarter revenues of $5.1 billion grew 7.3% on a reported basis or 5.9% on a currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021....
-
Nov 4, 2021
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend...
-
Oct 28, 2021BARDA to Invest $24.7 Million for BD to Develop New Tests for Core Labs, Hospitals and Point-of-Care Locations
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced...
-
Oct 26, 2021Event will provide strategic update, with focus on company's innovation and growth agendas
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will...
-
Oct 26, 2021- BD Veritor™ At-Home COVID-19 Test is now available for purchase on Amazon.com
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has started to ship the first over-the-counter (OTC) COVID-19 rapid antigen test to...
-
Oct 22, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company's board of directors,...
-
Oct 18, 2021Building on More Than Two Decades of Achievements, BD Making Bold ESG Commitments to Advance the World of Health for All
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as...
-
Oct 13, 2021
New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases FRANKLIN LAKES,...
-
Oct 7, 2021New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government's access to safety injection devices through...
-
Oct 6, 2021Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United States
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance for expanded indications from the U.S. Food and Drug...
-
Oct 4, 2021
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its fiscal 2021 fourth quarter and full year financial results on Thursday, Nov. 4, 2021. BD will issue a press...
-
Sep 22, 2021BD FACSymphony™ A5 SE (Spectral Enabled) Cell Analyzer offers users flexibility of using spectral or conventional flow cytometry analysis
FRANKLIN LAKES, N.J., Sept. 22, 2021 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a spectral-enabled cell...
-
Sep 22, 2021Company Signs Business Ambition for 1.5°C, Committing to Scope 1, 2 and 3 Greenhouse Gas Reduction Targets in Line with 1.5°C Emissions Scenarios in Order to Reach Science-Based Net Zero Emissions by 2050
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Global Citizen, is proud to announce the company has...
-
Sep 21, 2021BD Offers Digitally Read SARS-CoV-2 Rapid Antigen Test and Optional Turn-key Solution in 'Learn to Return' Program
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of Washington as a digitally read, rapid antigen test...
-
Sep 2, 2021Canaan Facility Produced First-Ever Disposable Syringe; Continues to Enable COVID-19 Vaccination Campaigns
CANAAN, Conn. (Sept. 2, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 60th anniversary of its manufacturing facility...
-
Aug 26, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor conferences:...
-
Aug 25, 2021- BD Veritor™ At-Home COVID-19 Test is Over-the-Counter, Rapid Antigen Test Using Scanwell Health Mobile App to Deliver Reliable Results in 15 Minutes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
-
Aug 25, 2021BD COR™ PX/GX System integrates robotics and sample management software algorithms to automate the complete molecular laboratory workflow from sample processing to diagnostic test result
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully automated high-throughput diagnostic system using...
-
Aug 19, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced tender offers to purchase for cash (i) any...
-
Aug 19, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced tender offers to purchase for cash (i) any and all of the...
-
Aug 11, 2021BD FACSymphony™ A1 Cell Analyzer offers powerful flow cytometry capabilities in a compact design
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry...
-
Aug 11, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher DelOrefice has been named executive vice president and chief financial...